CYMABAY THERAPEUTICS INC shareholders Q3 2023

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Nuveen Asset Management, LLC 699,392$10,427,9350.00%
Invesco Ltd. 941,808$14,042,3570.00%
TUDOR INVESTMENT CORP ET AL 24,769$369,3060.00%
Steward Partners Investment Advisory, LLC 15,350$228,8690.00%
GEODE CAPITAL MANAGEMENT, LLC 2,075,556$30,950,6150.00%
DEUTSCHE BANK AG\ 456,106$6,800,5410.00%
Hudson Bay Capital Management LP 60,000$894,6000.00%
METROPOLITAN LIFE INSURANCE CO/NY 5,668$84,5100.00%
PRICE T ROWE ASSOCIATES INC /MD/ 1,903,701$28,3850.00%
SG Americas Securities, LLC 15,449$2300.00%
Renaissance Technologies 113,450$1,6920.00%
Arizona State Retirement System 22,212$331,1810.00%
GLENMEDE TRUST CO NA 37,894$564,9990.00%
Squarepoint Ops LLC 83,901$1,250,9640.00%
NORTHERN TRUST CORP 1,007,512$15,022,0040.00%
STATE OF WISCONSIN INVESTMENT BOARD 71,934$1,072,5360.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 798,555$11,906,4550.00%
BlackRock Inc. 7,791,996$116,178,6620.00%
Raymond James Financial Services Advisors, Inc. 101,329$1,510,8150.00%
CAPTRUST FINANCIAL ADVISORS 45,509$678,5390.00%
External links

This page lists CYMABAY THERAPEUTICS INC's shareholders in Q3 2023. To view CYMABAY THERAPEUTICS INC's shareholder history, click here.